Mar 29, 2020
Michael T. McCaul- Amount
- Receipt pending ingestion
- Filed
- May 6, 2020
Congress ticker disclosure profile
As of August 1 at 5:15 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference CPF. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
25
Member filers
1
Disclosed ranges
Amount not disclosed
Most active member desks
20 buys vs 5 sells
Latest trade Mar 29, 2020
Mar 29, 2020
Michael T. McCaulMar 26, 2020
Michael T. McCaulMar 25, 2020
Michael T. McCaulMar 24, 2020
Michael T. McCaulDec 12, 2019
Michael T. McCaulMay 2, 2018
Michael T. McCaulMay 1, 2018
Michael T. McCaulApr 30, 2018
Michael T. McCaulApr 27, 2018
Michael T. McCaulApr 26, 2018
Michael T. McCaulApr 25, 2018
Michael T. McCaulApr 23, 2018
Michael T. McCaulApr 20, 2018
Michael T. McCaulApr 19, 2018
Michael T. McCaulApr 18, 2018
Michael T. McCaulApr 17, 2018
Michael T. McCaulApr 13, 2018
Michael T. McCaulApr 11, 2018
Michael T. McCaulApr 10, 2018
Michael T. McCaulApr 9, 2018
Michael T. McCaulApr 5, 2018
Michael T. McCaulApr 4, 2018
Michael T. McCaulApr 3, 2018
Michael T. McCaulApr 2, 2018
Michael T. McCaulMar 29, 2018
Michael T. McCaul| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Mar 29, 2020 | Michael T. McCaul | Sell | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Mar 26, 2020 | Michael T. McCaul | Sell | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Mar 25, 2020 | Michael T. McCaul | Sell | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Mar 24, 2020 | Michael T. McCaul | Sell | Receipt pending ingestion | May 6, 2020 | Receipt pending ingestion |
| Dec 12, 2019 | Michael T. McCaul | Sell | Receipt pending ingestion | Jan 29, 2020 | Open card |
| May 2, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | Jun 14, 2018 | Open card |
| May 1, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | Jun 14, 2018 | Open card |
| Apr 30, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 27, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 26, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 25, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 23, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 20, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 19, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 18, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 17, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 13, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 11, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 10, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 9, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 5, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 4, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 3, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Apr 2, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | May 15, 2018 | Open card |
| Mar 29, 2018 | Michael T. McCaul | Buy | Receipt pending ingestion | Apr 19, 2018 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 0 of 25 filed rows include disclosed amount ranges (0.0%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.